1H-cyclopenta[a]phenanthren-3-yl 2,2-dimethyl-1,3-dioxolane-4-carboxylate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 1H-cyclopenta[a]phenanthren-3-yl 2,2-dimethyl-1,3-dioxolane-4-carboxylate
• 化学式: C₂₃H₂₀O₄
• 分子量: 360.4
• InChiKey: XKPYDJNKYHAZHX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] STEROL DERIVATIVES AND USE THEREOF FOR TREATING DISEASES INVOLVING TRANSFORMED ASTROCYTE CELLS OR FOR TREATING MALIGNANT HAEMOPATHIES<br/>[FR] DÉRIVÉS DE STÉROL ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES IMPLIQUANT DES CELLULES ASTROCYTES TRANSFORMÉES OU DANS LE TRAITEMENT D'HÉMOPATHIES MALIGNES
  申请人：BETA INNOV

  公开号：WO2013168096A1

  公开（公告）日：2013-11-14

  The invention relates to novel sterol derivatives, the preparation method thereof, pharmaceutical compositions containing them and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies. The invention in particular relates to the treatment of glioblastoma multiforme, as well as of other cancers, such as lymphomas, neuroblastomas and melanomas.

  本发明涉及新型甾醇衍生物、其制备方法、含有它们的药物组合物以及用于治疗涉及转化星形胶质细胞或治疗恶性血液病的用途。本发明特别涉及治疗多形性胶质母细胞瘤以及其他癌症，如淋巴瘤、神经母细胞瘤和黑色素瘤。
• STEROL DERIVATIVES AND USE THEREOF FOR TREATING DISEASES INVOLVING TRANSFORMED ASTROCYTE CELLS OR FOR TREATING MALIGNANT HAEMOPATHIES
  申请人：Beta Innov

  公开号：EP2847204A1

  公开（公告）日：2015-03-18
• COMPOSITION CONTAINING A 7BETA-HYDROXYCHOLESTEROL AND A LIPID VEHICLE, AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES
  申请人：Beta Innov

  公开号：EP3820449A1

  公开（公告）日：2021-05-19
• [EN] COMPOSITION CONTAINING A 7BETA-HYDROXYCHOLESTEROL AND A LIPID VEHICLE, AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES<br/>[FR] COMPOSITION CONTENANT UN 7 BÊTA-HYDROXYCHOLESTÉROL ET UN VÉHICULE LIPIDIQUE, ET SON UTILISATION DANS LE TRAITEMENT DE PATHOLOGIES NÉOPLASIQUES
  申请人：BETA INNOV

  公开号：WO2020011916A1

  公开（公告）日：2020-01-16

  The invention relates to a composition comprising a 7β-hydroxycholesterol derivative and a lipid vehicle, in particular a vegetable oil, and use thereof in the treatment of neoplastic pathologies, such as glioblastoma multiforme. Said composition may be administered by the oral route.